DOCSLIB.ORG

The Health Benefits of Vitamin K (Box 1) on Bone Is Thought to Be Unrelated to Increasing BMD 19 Bone Health but Rather Increasing Bone Strength

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Health Benefits of Vitamin K (Box 1) on Bone Is Thought to Be Unrelated to Increasing BMD 19 Bone Health but Rather Increasing Bone Strength Review Open Heart: first published as 10.1136/openhrt-2015-000300 on 6 October 2015. Downloaded from The health benefits of vitamin K James J DiNicolantonio,1 Jaikrit Bhutani,2 James H O’Keefe1 To cite: DiNicolantonio JJ, ABSTRACT percentage of undercarboxylated osteocalcin ’ Bhutani J, O Keefe JH. The Vitamin K has important functions within the body, indicates poor vitamin K status, this value health benefits of vitamin K. some of which are still being discovered. Research has Open Heart 2015;2:e000300. can also vary based on recent vitamin K shown that vitamin K is an anticalcification, anticancer, 214 doi:10.1136/openhrt-2015- intake and supplementation and may not bone-forming and insulin-sensitising molecule. Recent 000300 indicate chronic vitamin K status. Moreover, data indicate that subclinical vitamin K deficiency is not a normal carboxylated MGP protein in the uncommon. Additionally, vitamin K antagonists such as warfarin may cause detrimental side effects, which serum may not necessarily indicate a normal Received 1 June 2015 may partly be blunted through vitamin K vitamin K status, as carboxylated MGP in the Revised 27 August 2015 serum could be normal, but suboptimal in Accepted 18 September 2015 supplementation. the arteries (where vitamin K2 is needed to prevent vascular calcification.) INTRODUCTION Vitamin K is a fat-soluble vitamin, important VITAMIN K AND BONE HEALTH for the function of numerous proteins within Osteoporosis is a leading contributor of frac- the body, such as the coagulation factors (II, tures worldwide, causing more than 8.9 VII, IX, X and protein C and protein S), million fractures annually.15 Moreover, osteocalcin (a bone-forming protein) and Osteoporosis affects an estimated 200 million matrix-Gla protein (MGP) (an anticalcifica- women worldwide (approximately 1/10th of – tion protein), to name a few.1 3 Vitamin K women aged 60, 1/5th of women aged 70, exists naturally as vitamin K1 (phylloquin- 2/5ths of women aged 80, and 2/3rds of 15 one) and vitamin K2 (menaquinone, MK-4 women aged 90). One in 3 women and 1 2–5 through MK-10). Vitamin K1 is mainly in 5 men over 50 will experience an osteo- porotic fracture.15 Additionally, 61% of all found in green leafy vegetables as well as http://openheart.bmj.com/ olive oil and soyabean oil, whereas vitamin osteoporotic fractures occur in women.15 It K2 (menaquinone) is found in small has been predicted that the incidence of hip amounts in chicken, butter, egg yolks, cheese fracture is expected to increase by 310% in and fermented soyabeans (better known as men and 240% in women by 2050; thus, the – natto).269 economic toll of osteoporosis is expected to fi 15 Vitamin K1 and vitamin K2 are required for signi cantly increase. Indeed, it has been the γ-glutamyl carboxylation of all vitamin estimated that there is a 40% lifetime risk for K-dependent proteins.2 Despite the fact that fractures affecting the hip, forearm and ver- mammalian bacterial intestinal flora are able tebrae (similar to the risk for cardiovascular on September 30, 2021 by guest. Protected copyright. 15 to produce vitamin K2, the amount produced disease), with nearly 75% of these types of is thought to be negligible.2 The adequate fractures occurring in patients aged 65 years intake (AI) for vitamin K has been proposed age and above.15 16 Osteoporosis has been to be 90 µg/day for women and 120 µg/day shown to account for more days spent in the for men.210However, it has been speculated hospital than diabetes, heart attacks or breast that the AI for vitamin K (90–120 µg/day) is cancer.15 It is also a major cause of disability, not sufficient to induce complete carboxyl- which has been shown to be greater than ation of all vitamin K-dependent that caused by cancer (except lung cancer) 1 Mid America Heart Institute proteins.21112 and comparable to or greater than disability at Saint Luke’s Hospital, Kansas City, Missouri, USA from rheumatoid arthritis, asthma and high 15 2Pt. BD Sharma Post blood pressure related heart disease. The Graduate Institute of Medical VITAMIN K DEFICIENCY overall mortality within the first 12 months Sciences, Rohtak, Haryana, The measurement and treatment of vitamin after a hip fracture is approximately 20%, India Kdeficiency based on blood tests is not being higher in men than women.15 – Correspondence to perfect. Plasma phylloquinone concentra- Moreover, men make up 20 25% of all hip 15 Dr James J DiNicolantonio; tions fluctuate based on recent dietary fractures, and have an estimated 30% life- [email protected] intakes.213Despite the fact that a high time risk of experiencing an osteoporotic DiNicolantonio JJ, Bhutani J, O’Keefe JH. Open Heart 2015;2:e000300. doi:10.1136/openhrt-2015-000300 1 Open Heart Open Heart: first published as 10.1136/openhrt-2015-000300 on 6 October 2015. Downloaded from fracture when over 50, similar to the lifetime risk of fracture, as there is a lack of evidence. The USPSTF also developing prostate cancer.15 Fragility fractures are the states that “Daily supplementation with ≤400 IU of primary cause of hospitalisation and/or death for US vitamin D3 and ≤1000 mg of calcium has no net benefit adults ≥age 65 and above.15 Furthermore, 44% of for the primary prevention of fractures” and that nursing home admissions are due to fractures.15 It is “Evidence is lacking regarding the benefit of daily sup- obvious that osteoporosis is extremely common and this plementation with >400 IU of vitamin D3 and >1000 mg condition leads to disability, costs and even death. Thus, of calcium for the primary prevention of fractures in preventing and treating this disease is of utmost import- postmenopausal women, and the balance of benefits ance. However, the recently updated USA Preventive and harms cannot be determined.”17 Thus, what else Services Task Force (USPSTF) has recently stated that can a clinician prescribe to help to prevent osteoporosis there is insufficient evidence that calcium and vitamin D and its consequences? A broad amount of data seems to prevent a fracture in premenopausal women or in men indicate substantial potential for supplementary vitamin who have not experienced a fracture and now recom- K. However, currently few guidelines recommend mends against daily supplementation with 400 IU or less vitamin K therapy for prevention or treatment of of vitamin D3 and 1000 mg or less of calcium for the osteoporosis. primary prevention of fractures in non-institutionalised Vitamin K1 (5 mg daily) given to 440 postmenopausal postmenopausal women. Thus, unless you are an institu- women with osteopenia for 2 years in a randomised, tionalised postmenopausal woman or you have already placebo-controlled, double-blind trial caused a greater experienced a fracture, the USPSTF does not recom- than 50% reduction in clinical fractures (9 vs 20, mend calcium and vitamin D for preventing a first-time p=0.04) versus placebo, despite the fact that there was no improvement in bone mineral density.18 Moreover, there was a 75% reduction in cancer incidence with fi vitamin K1 (3 vs 12, p=0.02). The bene t of vitamin K Box 1 The health benefits of vitamin K (box 1) on bone is thought to be unrelated to increasing BMD 19 Bone health but rather increasing bone strength. A recent May help to prevent fractures due to osteopenia and osteopor- meta-analysis has shown that vitamin K2 (45 mg/day) sig- osis18–20 nificantly reduces hip (77% reduction), vertebral (60% Trial evidence reduction) and all non-vertebral fractures (81% reduc- 20 Vitamin K1 (5 mg daily) given to 440 postmenopausal women tion). Whether the results of vitamin K2 at a dose of with osteopenia for 2 years in a randomised, placebo-controlled, 45 mg can be translated to over the counter doses of double-blind trial caused a greater than 50% reduction in clinical – vitamin K1 (such as 1 5 mg) is still a matter of debate, fractures (9 vs 20, p=0.04) versus placebo. but vitamin K on its own has already been shown to 1 http://openheart.bmj.com/ A recent meta-analysis has shown that vitamin K2 (45 mg/day) reduce fractures and cancer in a clinical trial, although significantly reduces hip (77% reduction), vertebral (60% reduc- more data are needed to confirm these benefits. tion) and all non-vertebral fractures (81% reduction).20 Cancer (especially liver cancer) May help to prevent liver cancer and death in patients with liver cirrhosis and hepatocellular carcinoma (HCC)54–61 VITAMIN K AND VASCULAR CALCIFICATIONS Trial evidence Coronary artery calcium (CAC) has been shown to have 3 Five randomised controlled trials tested vitamin K2 (45 or 90 mg/ increasing prevalence as kidney function declines. day) in patients with HCC. Vitamin K2 significantly improved Indeed, CAC prevalence has been reported in 13% of 74 1-year overall survival, (RR=1.03, 95% CI 1.00 to 1.05, p=0.03) ‘healthy’ patients without renal disease,21 40% of on September 30, 2021 by guest. Protected copyright. Vascular calcifications patients with chronic kidney disease patients not on dia- May help to prevent vascular calcifications (especially in patients 21 22 52675 lysis, 57% of patients starting dialysis and 83% of on warfarin) 23 Trial evidence patients on long-term dialysis. Diets lacking vitamin K can precipitate the development of vitamin K deficiency Significantly delayed the development of coronary artery calcium in as little as 7 days.24 Additionally, subclinical vitamin K in a 3-year, double-blind, randomised controlled trial of 452 fi patients. de ciency is not uncommon, especially in patients 25 In a 3-year, double-blind, placebo-controlled trial, vitamin K1 receiving warfarin.
Load more

Recommended publications
  • Dispensing of Vitamin Products by Retail Pharmacies in South Africa: Implications for Dietitians
    South African Journal of Clinical Nutrition 2016; 29(4):133–138 http://dx.doi.org/10.1080/16070658.2016.1219468 SAJCN ISSN 1607-0658 EISSN 2221-1268 Open Access article distributed under the terms of the © 2016 The Author(s) Creative Commons License [CC BY-NC 3.0] http://creativecommons.org/licenses/by-nc/3.0 RESEARCH Dispensing of vitamin products by retail pharmacies in South Africa: Implications for dietitians Ilse Trutera* and Liana Steenkampb a Department of Pharmacy, Drug Utilisation Research Unit (DURU), Nelson Mandela Metropolitan University, Port Elizabeth, South Africa b HIV & AIDS Research Unit, Nelson Mandela Metropolitan University, Port Elizabeth, South Africa *Corresponding author, email: [email protected] Objective: The objective of this study was to analyse the dispensing patterns of vitamins (Anatomical Therapeutic Chemical (ATC) group A11) over a one-year period in a group of community pharmacies in South Africa. Design and setting: A retrospective drug utilisation study was conducted on community pharmacy electronic dispensing records in South Africa recorded in 2013. Outcome measures: All products for ATC subgroup A11 were extracted and analysed. Results: A total of 164 233 vitamin products were dispensed to 84 805 patients (62.64% female patients). Males received on average 2.09 (SD = 2.63) vitamin products per year, compared to 1.84 (SD = 2.13) products for females. Ergocalciferol (A11CC01) was the most often dispensed (37.48% of all vitamin products), followed by plain Vitamin B-complex products (A11EA00) accounting for 32.77%. Ergocalciferol (vitamin D2) is only available on prescription (50 000 IU tablets or 50 000 IU/ml oily drops) in South Africa.
    [Show full text]
  • Vitamin K: Double Bonds Beyond Coagulation Insights Into Differences Between Vitamin K1 and K2 in Health and Disease
    International Journal of Molecular Sciences Review Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease Maurice Halder 1,†, Ploingarm Petsophonsakul 2,†, Asim Cengiz Akbulut 2,†, Angelina Pavlic 2,† , Frode Bohan 3, Eric Anderson 3, Katarzyna Maresz 4, Rafael Kramann 1 and Leon Schurgers 1,2,* 1 Division of Nephrology, RWTH Aachen University, 52074 Aachen, Germany; [email protected] (M.H.); [email protected] (R.K.) 2 Department of Biochemistry, Cardiovascular Research Institute Maastricht, 6200MD Maastricht, The Netherlands; [email protected] (P.P.); [email protected] (A.C.A.); [email protected] (A.P.) 3 NattoPharma ASA, 0283 Oslo, Norway; [email protected] (F.B.); [email protected] (E.A.) 4 International Science & Health Foundation, 30-134 Krakow, Poland; [email protected] * Correspondence: [email protected]; Tel.: +31-43-3881680; Fax: +31-43-3884159 † These authors contributed equally to this work. Received: 24 January 2019; Accepted: 16 February 2019; Published: 19 February 2019 Abstract: Vitamin K is an essential bioactive compound required for optimal body function. Vitamin K can be present in various isoforms, distinguishable by two main structures, namely, phylloquinone (K1) and menaquinones (K2). The difference in structure between K1 and K2 is seen in different absorption rates, tissue distribution, and bioavailability. Although differing in structure, both act as cofactor for the enzyme gamma-glutamylcarboxylase, encompassing both hepatic and extrahepatic activity. Only carboxylated proteins are active and promote a health profile like hemostasis. Furthermore, vitamin K2 in the form of MK-7 has been shown to be a bioactive compound in regulating osteoporosis, atherosclerosis, cancer and inflammatory diseases without risk of negative side effects or overdosing.
    [Show full text]
  • Control of Interstitial Pneumonia by Drip Infusion of Megadose Vitamin C, Dehydroepiandrosterone and Cortisol
    in vivo 22 : 263-268 (2008) Short Review Control of Interstitial Pneumonia by Drip Infusion of Megadose Vitamin C, Dehydroepiandrosterone and Cortisol. A Short Review of our Experience MITSUO KODAMA 1, ATSUSHI OYAMA 2 and HIROSHI TAKAGI 3 1Kodama Research Institute of Preventive Medicine, 2Hikarigaoka Clinic, and 3Second Department of Surgery, Nagoya University School of Medicine, Nagoya, Japan Abstract. Interstitial pneumonia can be controlled by the granulatory tissue (1). The interstitial tissues are also combined use of a prophylactic antibiotic system and the drip involved in the site of granulation (1). All these descriptions infusion system including megadose vitamin C, dehydro- are in good agreement with the pathological changes of epiandrosterone (D) and cortisol (F), a fortified substitute of 3 interstitial pneumonia (2). In the treatment section, adrenocortical elements. The response of patients was satisfying Heilmeyer warned of the possible emergence of antibiotic with few side-effects of F. It was shown that an excess of resistance in local bacteria (1). Eventually, cortisone and vitamin C improved the therapeutic efficacy of D-F complex, adrenocorticotropic hormone (ACTH) could be tried under and that D and F improved the immunodeficient state of the the antibiotic protection (1). Above all, attention should be host. The benefit of D as an adrenal androgen in immunology directed to the control of both the heart and the general found another example in the combined use of cyclosporine A circulation system (1). With the use of cortisone and ACTH, (CS) and glucocorticoid (G) in the kidney transplantation Heilmeyer might have been inspired by the opinion of a clinic: CS and G helps improve graft take by creating a state of group of researchers that his chronic pneumonia might androgen excess, as testified in both humans and mice – an respond to a beneficial action of glucocorticoid, as is the alleviation of immune conflict.
    [Show full text]
  • Suppression of Prostate Tumor Cell Growth by Stromal Cell Prostaglandin D Synthase–Derived Products
    Research Article Suppression of Prostate Tumor Cell Growth by Stromal Cell Prostaglandin D Synthase–Derived Products Jeri Kim,1 Peiying Yang,2 Milind Suraokar,3 Anita L. Sabichi,3 Norma D. Llansa,3 Gabriela Mendoza,3 Vemparalla Subbarayan,3 Christopher J. Logothetis,1 Robert A. Newman,2 Scott M. Lippman,3 and David G. Menter3 Departments of 1Genitourinary Medical Oncology, 2Experimental Therapeutics, and 3Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, Texas Abstract seminal fluid (10). Once PGD2 is made, it forms derivative Stromal-epithelial interactions and the bioactive molecules compounds, most of which can transactivate the peroxisome g g produced by these interactions maintain tissue homeostasis proliferator–activated receptor (PPAR ). One PGD2 derivative, 15-deoxy-D12,14-prostaglandin J (15-d-PGJ ), can slow the growth and influence carcinogenesis. Bioactive prostaglandins pro- 2 2 duced by prostaglandin synthases and secreted by the prostate and induce the partial differentiation of selected cancer cells (12). D12,14 into seminal plasma are thought to support reproduction, but Another PGD2 derivative, 15-deoxy- -PGD2 (15-d-PGD2), has g their endogenous effects on cancer formation remain unre- also been shown to stimulate PPAR transactivation in RAW 264.7 solved. No studies to date have examined prostaglandin cell macrophage cultures as effectively as 15-d-PGJ2 (13). L-PGDS enzyme production or prostaglandin metabolism in normal also binds tritiated testosterone and may play a role in androgen prostate stromal cells. Our results show that lipocalin-type transport (14). In castrated rats, testosterone proprionate induces prostaglandin D synthase (L-PGDS) and prostaglandin D L-PGDS synthesis in the epididymis (15).
    [Show full text]
  • Outpatient Acne Care Guideline
    Outpatient Acne Care Guideline Severity Mild Moderate Severe < 20 comedones or < 20-100 comedones or 15-50 > 5 cysts, >100 comedones, or inflammatory lesions inflammatory lesions >50 inflammatory lesions Initial Treatment Initial Treatment Initial Treatment Benzoyl Peroxide (BP) or Topical Combination Therapy Combination Therapy Topical Retinoid Retinoid + BP Oral antibiotic or OR + (Retinoid + Antibiotic) + BP Topical retinoid Topical Combination Therapy or + BP + Antibiotic Retinoid + (BP + Antibiotic) or OR BP Retinoid + BP Oral antibiotic + topical retinoid + +/- or BP Topical antibiotic Retinoid + Antibiotic + BP or Topical Dapsone IF Inadequate Response IF Inadequate Response IF Inadequate Consider dermatology Response referral Change topical retinoid Consider changing oral concentrations, type and/or antibiotic formulation AND or Add BP or retinoid, if not already Change topiocal combination Consider isotretinoin prescribed therapy Consider hormone therapy or and/or (females) Change topical retinoid Add or change oral antibiotic concentrations, type and/or or formulation Consider isotretinoin Additional Considerations or Consider hormone therapy (females) Change topical comination Previous treatment/history Side effects therapy Costs Psychosocial impact Vehicle selection Active scarring Ease of use Regimen complexity Approved Evidence Based Medicine Committee 1-18-17 Reassess the appropriateness of Care Guidelines as condition changes. This guideline is a tool to aid clinical decision making. It is not a standard of care. The physician should deviate from the guideline when clinical judgment so indicates. GOAL: Pediatricians should initiate treatment for cases of “Mild” to “Severe” acne (see algorithms attached). Pediatricians should also counsel patients in order to maximize adherence to acne treatment regimens: 1. Realistic expectations. Patients should be counseled that topical therapies typically take up to 6-8 weeks to start seeing results.
    [Show full text]
  • Multicenter Randomized Controlled Trial of Vitamin K Antagonist
    CLINICAL RESEARCH www.jasn.org Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study An S. De Vriese ,1,2 Rogier Caluwé ,3 Lotte Pyfferoen,4 Dirk De Bacquer,5 Koen De Boeck,6 Joost Delanote,4 Didier De Surgeloose,7 Piet Van Hoenacker,8 Bruno Van Vlem,3 and Francis Verbeke 9 1Division of Nephrology and Infectious Diseases and 4Department of Medical Imaging, AZ Sint-Jan Brugge, Brugge, Belgium; Departments of 2Internal Medicine and 5Public Health, Ghent University, Ghent, Belgium; 3Division of Nephrology and 8Department of Medical Imaging, Onze Lieve Vrouw Hospital, Aalst, Belgium; 6Division of Nephrology and 7Department of Medical Imaging, ZNA Middelheim, Antwerp, Belgium; and 9Division of Nephrology, University Hospital, Ghent, Belgium ABSTRACT Background Vitamin K antagonists (VKAs), although commonly used to reduce thromboembolic risk in atrial fibrillation, have been incriminated as probable cause of accelerated vascular calcification (VC) in patients on hemodialysis. Functional vitamin K deficiency may further contribute to their susceptibility for VC. We investigated the effect of vitamin K status on VC progression in 132 patients on hemodialysis with atrial fibrillation treated with VKAs or qualifying for anticoagulation. Methods Patients were randomized to VKAs with target INR 2–3, rivaroxaban 10 mg daily, or rivaroxaban 10 mg daily plus vitamin K2 2000 mg thrice weekly during 18 months. Systemic dp-ucMGP levels were quantified to assess vascular vitamin K status. Cardiac and thoracic aorta calcium scores and pulse wave velocity were measured to evaluate VC progression. Results Baseline dp-ucMGP was severely elevated in all groups.
    [Show full text]
  • Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women
    nutrients Article Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women Pramod B. Umarji 1, Pankaj Verma 2, Vivek Garg 2, Marian Schini 3,* and Richard Eastell 3 1 Umarji Healthcare, Pune, Maharashtra 411045, India; [email protected] 2 Hindustan Unilever Limited R&D, Gurugram, Haryana 122002, India; [email protected] (P.V.); [email protected] (V.G.) 3 Academic Unit of Bone Metabolism, University of Sheffield, Sheffield S10 2NR, UK; r.eastell@sheffield.ac.uk * Correspondence: m.schini@sheffield.ac.uk; Tel.: +44-0114-215-9667 Abstract: Young Indian women may be at risk of poor bone health due to malnutrition. The aim of this study was to examine the effects on bone metabolism of a nutritional supplement in women aged 25 to 44. The nutritional supplement was a protein-rich beverage powder fortified with multi- micronutrients including calcium (600 mg), vitamin D (400 IU), and vitamin K (55 mcg) per daily serving, while a placebo supplement was low-protein non-fortified isocaloric beverage powder. This 6-month randomised, controlled trial showed favorable changes in bone turnover markers (decreased) and calcium homeostasis; such changes in older adults have been associated with slowing of bone loss and reduced fracture risk. For example, serum CTX decreased by about 30% and PINP by about 20% as a result of the increase in calcium intake. There were also changes in the ratio of carboxylated to undercarboxylated osteocalcin and such changes have been linked to a slowing of bone loss in older subjects. For example, the ratio increased by about 60% after 3 months as a result in the improvement in vitamin K status.
    [Show full text]
  • Optimal Foods
    Optimal Foods 1. Almonds: high in monounsaturated and polyunsaturated fats, with 20% of calories coming from protein and dietary fiber. Nutrients include potassium, magnesium, calcium, iron, zinc, vitamin E and an antioxidant flavonoid called amygdlin also known as laetrile. 2. Barley: Like oat bran it is high in beta-glucan fiber which helps to lower cholesterol. Nutrients include copper, magnesium, phosphorous and niacin. 3. Berries : The darker the berry the higher in anti-oxidants. Nutritionally they are an excellent source of flavonoids, especially anthocyanidins, vitamin C and both soluble and insoluble fiber. 4. Brussels Sprouts : Similar to broccoli, and a member of the cabbage family, it contains cancer fighting glucosinolates. Nutritionally it is an excellent source of vitamin C and K, the B vitamins, beta-carotene, potassium and dietary fiber. 5. Carrots: It contains the highest source of proviatamin A carotenes as well as vitamin K, biotin, vitamin C, B6, potassium, thiamine and fiber. 6. Dark Chocolate: It is rich in the flavonoids, similar to those found in berries and apples, that are more easily absorbed than in other foods. It also provides an amino acid called arginine that helps blood vessels to dilate hence regulating blood flow and helping to lower blood pressure. Choose high-quality semisweet dark chocolate with the highest cocoa content that appeals to your taste buds. 7. Dark leafy greens : Kale, arugula, spinach, mustard greens, chard, collards, etc: low calorie, anti-oxidant dense food with carotenes, vitamin C, folic acid, manganese, copper, vitamin E, copper, vitamin B6, potassium, calcium, iron and dietary fiber. Kale is a particularly excellent bioavailable source of calcium while spinach is not.
    [Show full text]
  • The Effect of Vitamin Supplementation on Subclinical
    molecules Review The Effect of Vitamin Supplementation on Subclinical Atherosclerosis in Patients without Manifest Cardiovascular Diseases: Never-ending Hope or Underestimated Effect? Ovidiu Mitu 1,2,* , Ioana Alexandra Cirneala 1,*, Andrada Ioana Lupsan 3, Mircea Iurciuc 4 , 5 5 2, Ivona Mitu , Daniela Cristina Dimitriu , Alexandru Dan Costache y , Antoniu Octavian Petris 1,2 and Irina Iuliana Costache 1,2 1 Department of Cardiology, Clinical Emergency Hospital “Sf. Spiridon”, 700111 Iasi, Romania 2 1st Medical Department, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania 3 Department of Cardiology, University of Medicine, Pharmacy, Science and Technology, 540139 Targu Mures, Romania 4 Department of Cardiology, University of Medicine and Pharmacy “Victor Babes”, 300041 Timisoara, Romania 5 2nd Morpho-Functional Department, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania * Correspondence: [email protected] (O.M.); [email protected] (I.A.C.); Tel.: +40-745-279-714 (O.M.) Medical Student, University of Medicine and Pharmacy “Grigore T. Popa”, 700115 Iasi, Romania. y Academic Editors: Raluca Maria Pop, Ada Popolo and Stefan Cristian Vesa Received: 25 March 2020; Accepted: 7 April 2020; Published: 9 April 2020 Abstract: Micronutrients, especially vitamins, play an important role in the evolution of cardiovascular diseases (CVD). It has been speculated that additional intake of vitamins may reduce the CVD burden by acting on the inflammatory and oxidative response starting from early stages of atherosclerosis, when the vascular impairment might still be reversible or, at least, slowed down. The current review assesses the role of major vitamins on subclinical atherosclerosis process and the potential clinical implications in patients without CVD.
    [Show full text]
  • Vitamin K the “Forgotten” Vitamin
    Vitamin K The “Forgotten” Vitamin Ask anybody what vitamins they know about, and you’re likely to hear Vitamin C, Vitamin D, Vitamin E, and many people will even know that there are multiple vitamins called B. But if you ask about Vitamin K, a lot of people will say “is that really a thing?” Well, we’re here to tell you that not only is it a thing, but it’s as essential as any of the other vitamins you may have heard of. That’s why it’s one of the so-called “13 Essential Vitamins,” which are actually REQUIRED by our bodies in order to Function. Complicating matters even more is the fact that Vitamin K is actually a COMPLEX of vitamins, each with its own distinct properties. In order to understand Vitamin K, its importance in our diet, how to make sure we’re getting all the benefits of it, and how it interacts with other vitamins, we need to know what it is, what it does, what foods it can be found in, and what the different types are. Not Just One Vitamin Just as Vitamin B is actually a whole group of vitamins (B6, B12, Niacin, Riboflavin, etc.), Vitamin K is also a group of compounds, and not just one vitamin. The two most important of these are K1 and K2. There is also a synthetic form of Vitamin K known a K3, but as it can be toxic, it is not generally used in supplementation. Clean, Quiet, & Dark To make things even more complicated, there are two different forms of Vitamin K2 – MK4 and MK7.
    [Show full text]
  • All There Is to C • Vitamin C and Health the Vitamin C Essentials • Getting Your Vitamin C
    Overview • Journey at C: Vitamin C in the Body All There is to C • Vitamin C and Health The vitamin C essentials • Getting Your Vitamin C Alexander Michels PhD • Vitamin C Myths Linus Pauling Institute Oregon State University May 11th, 2015 Journey at C Journey at C Vitamin C is Ascorbic Acid Vitamin C in the Small Intestine Ascorbic acid is vitamin C by definition: Only sources of ascorbic acid can cure scurvy. Image Source: Wikimedia Commons Extra vitamin C beyond the transport capacity passes through to the large intestine and may be lost Sodium-dependent Vitamin C Journey at C Transporters (SVCTs) Journey at C Vitamin C Intestinal Absorption Absorption and Vitamin C Transporters Ascorbic Acid Dehydroascorbic Acid (Oxidized form of Ascorbic Acid) Glucose Transporters (GLUTs) Remember: There is a limit to vitamin C absorption! 1 Note: Tissue ascorbic acid levels on this slide are hypothetical, but are driven by plasma vitamin C levels. As plasma levels increase, different tissues increase vitamin C Journey at C levels at different rates. The brain is given priority at low Journey at C vitamin C levels, while less essential organs are saturated Vitamin C in Tissues with vitamin C only at higher blood ascorbic acid levels. Vitamin C from Circulation to Tissues Plasma levels peak about 2 hours after a single dose. Vitamin C is transported into tissues when plasma levels rise. From Michels et al. Ann Rev Nutr 33 (2013) Vitamin C levels decline in the Journey at C plasma once kidney reuptake is Journey at C saturated, which also means that Vitamin C Urinary Excretion more passes through to the urine.
    [Show full text]
  • Vitamin K2 Needs an RDI Separate from Vitamin K1
    nutrients Review Vitamin K2 Needs an RDI Separate from Vitamin K1 1, 1, 1, Asim Cengiz Akbulut y, Angelina Pavlic y , Ploingarm Petsophonsakul y , 2, 3 2 1,2, Maurice Halder y , Katarzyna Maresz , Rafael Kramann and Leon Schurgers * 1 Department of Biochemistry, Cardiovascular Research Institute Maastricht, 6200MD Maastricht, The Netherlands; [email protected] (A.C.A.); [email protected] (A.P.); [email protected] (P.P.) 2 Division of Nephrology, RWTH Aachen University, 52074 Aachen, Germany; [email protected] (M.H.); [email protected] (R.K.) 3 International Science & Health Foundation, 30-134 Krakow, Poland; [email protected] * Correspondence: [email protected]; Tel.: +31-43-3881680; Fax: +31-43-3884159 These authors contributed equally to this work. y Received: 25 May 2020; Accepted: 17 June 2020; Published: 21 June 2020 Abstract: Vitamin K and its essential role in coagulation (vitamin K [Koagulation]) have been well established and accepted the world over. Many countries have a Recommended Daily Intake (RDI) for vitamin K based on early research, and its necessary role in the activation of vitamin K-dependent coagulation proteins is known. In the past few decades, the role of vitamin K-dependent proteins in processes beyond coagulation has been discovered. Various isoforms of vitamin K have been identified, and vitamin K2 specifically has been highlighted for its long half-life and extrahepatic activity, whereas the dietary form vitamin K1 has a shorter half-life. In this review, we highlight the specific activity of vitamin K2 based upon proposed frameworks necessary for a bioactive substance to be recommended for an RDI.
    [Show full text]